1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Epilepsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Partial/focal Seizure 1.2.3 Generalized Seizure 1.2.4 Myoclonus Misses 1.2.5 Negative Myoclonus 1.2.6 Eyelid Myoclonus 1.2.7 Laughter 1.2.8 Others 1.3 Market by Application 1.3.1 Global Epilepsy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Neurology Centers 1.3.4 Home Care Settings 1.3.5 Ambulatory Surgical Centers 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Epilepsy Market Perspective (2016-2027) 2.2 Epilepsy Growth Trends by Regions 2.2.1 Epilepsy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Epilepsy Historic Market Share by Regions (2016-2021) 2.2.3 Epilepsy Forecasted Market Size by Regions (2022-2027) 2.3 Epilepsy Industry Dynamic 2.3.1 Epilepsy Market Trends 2.3.2 Epilepsy Market Drivers 2.3.3 Epilepsy Market Challenges 2.3.4 Epilepsy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Epilepsy Players by Revenue 3.1.1 Global Top Epilepsy Players by Revenue (2016-2021) 3.1.2 Global Epilepsy Revenue Market Share by Players (2016-2021) 3.2 Global Epilepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Epilepsy Revenue 3.4 Global Epilepsy Market Concentration Ratio 3.4.1 Global Epilepsy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Revenue in 2020 3.5 Epilepsy Key Players Head office and Area Served 3.6 Key Players Epilepsy Product Solution and Service 3.7 Date of Enter into Epilepsy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Epilepsy Breakdown Data by Type 4.1 Global Epilepsy Historic Market Size by Type (2016-2021) 4.2 Global Epilepsy Forecasted Market Size by Type (2022-2027) 5 Epilepsy Breakdown Data by Application 5.1 Global Epilepsy Historic Market Size by Application (2016-2021) 5.2 Global Epilepsy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Epilepsy Market Size (2016-2027) 6.2 North America Epilepsy Market Size by Type 6.2.1 North America Epilepsy Market Size by Type (2016-2021) 6.2.2 North America Epilepsy Market Size by Type (2022-2027) 6.2.3 North America Epilepsy Market Size by Type (2016-2027) 6.3 North America Epilepsy Market Size by Application 6.3.1 North America Epilepsy Market Size by Application (2016-2021) 6.3.2 North America Epilepsy Market Size by Application (2022-2027) 6.3.3 North America Epilepsy Market Size by Application (2016-2027) 6.4 North America Epilepsy Market Size by Country 6.4.1 North America Epilepsy Market Size by Country (2016-2021) 6.4.2 North America Epilepsy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Epilepsy Market Size (2016-2027) 7.2 Europe Epilepsy Market Size by Type 7.2.1 Europe Epilepsy Market Size by Type (2016-2021) 7.2.2 Europe Epilepsy Market Size by Type (2022-2027) 7.2.3 Europe Epilepsy Market Size by Type (2016-2027) 7.3 Europe Epilepsy Market Size by Application 7.3.1 Europe Epilepsy Market Size by Application (2016-2021) 7.3.2 Europe Epilepsy Market Size by Application (2022-2027) 7.3.3 Europe Epilepsy Market Size by Application (2016-2027) 7.4 Europe Epilepsy Market Size by Country 7.4.1 Europe Epilepsy Market Size by Country (2016-2021) 7.4.2 Europe Epilepsy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Epilepsy Market Size (2016-2027) 8.2 Asia-Pacific Epilepsy Market Size by Type 8.2.1 Asia-Pacific Epilepsy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Epilepsy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Epilepsy Market Size by Type (2016-2027) 8.3 Asia-Pacific Epilepsy Market Size by Application 8.3.1 Asia-Pacific Epilepsy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Epilepsy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Epilepsy Market Size by Application (2016-2027) 8.4 Asia-Pacific Epilepsy Market Size by Region 8.4.1 Asia-Pacific Epilepsy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Epilepsy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Epilepsy Market Size (2016-2027) 9.2 Latin America Epilepsy Market Size by Type 9.2.1 Latin America Epilepsy Market Size by Type (2016-2021) 9.2.2 Latin America Epilepsy Market Size by Type (2022-2027) 9.2.3 Latin America Epilepsy Market Size by Type (2016-2027) 9.3 Latin America Epilepsy Market Size by Application 9.3.1 Latin America Epilepsy Market Size by Application (2016-2021) 9.3.2 Latin America Epilepsy Market Size by Application (2022-2027) 9.3.3 Latin America Epilepsy Market Size by Application (2016-2027) 9.4 Latin America Epilepsy Market Size by Country 9.4.1 Latin America Epilepsy Market Size by Country (2016-2021) 9.4.2 Latin America Epilepsy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Epilepsy Market Size (2016-2027) 10.2 Middle East & Africa Epilepsy Market Size by Type 10.2.1 Middle East & Africa Epilepsy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Epilepsy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Epilepsy Market Size by Type (2016-2027) 10.3 Middle East & Africa Epilepsy Market Size by Application 10.3.1 Middle East & Africa Epilepsy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Epilepsy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Epilepsy Market Size by Application (2016-2027) 10.4 Middle East & Africa Epilepsy Market Size by Country 10.4.1 Middle East & Africa Epilepsy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Epilepsy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 LivaNova 11.1.1 LivaNova Company Details 11.1.2 LivaNova Business Overview 11.1.3 LivaNova Epilepsy Introduction 11.1.4 LivaNova Revenue in Epilepsy Business (2016-2021) 11.1.5 LivaNova Recent Development 11.2 Johnson & Johnson Services 11.2.1 Johnson & Johnson Services Company Details 11.2.2 Johnson & Johnson Services Business Overview 11.2.3 Johnson & Johnson Services Epilepsy Introduction 11.2.4 Johnson & Johnson Services Revenue in Epilepsy Business (2016-2021) 11.2.5 Johnson & Johnson Services Recent Development 11.3 Eisai 11.3.1 Eisai Company Details 11.3.2 Eisai Business Overview 11.3.3 Eisai Epilepsy Introduction 11.3.4 Eisai Revenue in Epilepsy Business (2016-2021) 11.3.5 Eisai Recent Development 11.4 GlaxoSmithKline PLC 11.4.1 GlaxoSmithKline PLC Company Details 11.4.2 GlaxoSmithKline PLC Business Overview 11.4.3 GlaxoSmithKline PLC Epilepsy Introduction 11.4.4 GlaxoSmithKline PLC Revenue in Epilepsy Business (2016-2021) 11.4.5 GlaxoSmithKline PLC Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Epilepsy Introduction 11.5.4 Pfizer Revenue in Epilepsy Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 UCB SA 11.6.1 UCB SA Company Details 11.6.2 UCB SA Business Overview 11.6.3 UCB SA Epilepsy Introduction 11.6.4 UCB SA Revenue in Epilepsy Business (2016-2021) 11.6.5 UCB SA Recent Development 11.7 Medtronic PLC (Ireland) 11.7.1 Medtronic PLC (Ireland) Company Details 11.7.2 Medtronic PLC (Ireland) Business Overview 11.7.3 Medtronic PLC (Ireland) Epilepsy Introduction 11.7.4 Medtronic PLC (Ireland) Revenue in Epilepsy Business (2016-2021) 11.7.5 Medtronic PLC (Ireland) Recent Development 11.8 NeuroPace 11.8.1 NeuroPace Company Details 11.8.2 NeuroPace Business Overview 11.8.3 NeuroPace Epilepsy Introduction 11.8.4 NeuroPace Revenue in Epilepsy Business (2016-2021) 11.8.5 NeuroPace Recent Development 11.9 Novartis AG 11.9.1 Novartis AG Company Details 11.9.2 Novartis AG Business Overview 11.9.3 Novartis AG Epilepsy Introduction 11.9.4 Novartis AG Revenue in Epilepsy Business (2016-2021) 11.9.5 Novartis AG Recent Development 11.10 GW Pharmaceuticals 11.10.1 GW Pharmaceuticals Company Details 11.10.2 GW Pharmaceuticals Business Overview 11.10.3 GW Pharmaceuticals Epilepsy Introduction 11.10.4 GW Pharmaceuticals Revenue in Epilepsy Business (2016-2021) 11.10.5 GW Pharmaceuticals Recent Development 11.11 Abbott Laboratories 11.11.1 Abbott Laboratories Company Details 11.11.2 Abbott Laboratories Business Overview 11.11.3 Abbott Laboratories Epilepsy Introduction 11.11.4 Abbott Laboratories Revenue in Epilepsy Business (2016-2021) 11.11.5 Abbott Laboratories Recent Development 11.12 Sanofi 11.12.1 Sanofi Company Details 11.12.2 Sanofi Business Overview 11.12.3 Sanofi Epilepsy Introduction 11.12.4 Sanofi Revenue in Epilepsy Business (2016-2021) 11.12.5 Sanofi Recent Development 11.13 Sunovion Pharmaceuticals 11.13.1 Sunovion Pharmaceuticals Company Details 11.13.2 Sunovion Pharmaceuticals Business Overview 11.13.3 Sunovion Pharmaceuticals Epilepsy Introduction 11.13.4 Sunovion Pharmaceuticals Revenue in Epilepsy Business (2016-2021) 11.13.5 Sunovion Pharmaceuticals Recent Development 11.14 Bausch Health 11.14.1 Bausch Health Company Details 11.14.2 Bausch Health Business Overview 11.14.3 Bausch Health Epilepsy Introduction 11.14.4 Bausch Health Revenue in Epilepsy Business (2016-2021) 11.14.5 Bausch Health Recent Development 11.15 Takeda 11.15.1 Takeda Company Details 11.15.2 Takeda Business Overview 11.15.3 Takeda Epilepsy Introduction 11.15.4 Takeda Revenue in Epilepsy Business (2016-2021) 11.15.5 Takeda Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Epilepsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Partial/focal Seizure Table 3. Key Players of Generalized Seizure Table 4. Key Players of Myoclonus Misses Table 5. Key Players of Negative Myoclonus Table 6. Key Players of Eyelid Myoclonus Table 7. Key Players of Laughter Table 8. Key Players of Others Table 9. Global Epilepsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Epilepsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Epilepsy Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Epilepsy Market Share by Regions (2016-2021) Table 13. Global Epilepsy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Epilepsy Market Share by Regions (2022-2027) Table 15. Epilepsy Market Trends Table 16. Epilepsy Market Drivers Table 17. Epilepsy Market Challenges Table 18. Epilepsy Market Restraints Table 19. Global Epilepsy Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Epilepsy Market Share by Players (2016-2021) Table 21. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy as of 2020) Table 22. Ranking of Global Top Epilepsy Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Epilepsy Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Epilepsy Product Solution and Service Table 26. Date of Enter into Epilepsy Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Epilepsy Market Size by Type (2016-2021) (US$ Million) Table 29. Global Epilepsy Revenue Market Share by Type (2016-2021) Table 30. Global Epilepsy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Epilepsy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Epilepsy Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Epilepsy Revenue Market Share by Application (2016-2021) Table 34. Global Epilepsy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Epilepsy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Epilepsy Market Size by Type (2016-2021) (US$ Million) Table 37. North America Epilepsy Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Epilepsy Market Size by Application (2016-2021) (US$ Million) Table 39. North America Epilepsy Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Epilepsy Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Epilepsy Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Epilepsy Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Epilepsy Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Epilepsy Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Epilepsy Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Epilepsy Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Epilepsy Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Epilepsy Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Epilepsy Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Epilepsy Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Epilepsy Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Epilepsy Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Epilepsy Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Epilepsy Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Epilepsy Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Epilepsy Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Epilepsy Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Epilepsy Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Epilepsy Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Epilepsy Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Epilepsy Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Epilepsy Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Epilepsy Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Epilepsy Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Epilepsy Market Size by Country (2022-2027) & (US$ Million) Table 66. LivaNova Company Details Table 67. LivaNova Business Overview Table 68. LivaNova Epilepsy Product Table 69. LivaNova Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 70. LivaNova Recent Development Table 71. Johnson & Johnson Services Company Details Table 72. Johnson & Johnson Services Business Overview Table 73. Johnson & Johnson Services Epilepsy Product Table 74. Johnson & Johnson Services Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 75. Johnson & Johnson Services Recent Development Table 76. Eisai Company Details Table 77. Eisai Business Overview Table 78. Eisai Epilepsy Product Table 79. Eisai Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 80. Eisai Recent Development Table 81. GlaxoSmithKline PLC Company Details Table 82. GlaxoSmithKline PLC Business Overview Table 83. GlaxoSmithKline PLC Epilepsy Product Table 84. GlaxoSmithKline PLC Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 85. GlaxoSmithKline PLC Recent Development Table 86. Pfizer Company Details Table 87. Pfizer Business Overview Table 88. Pfizer Epilepsy Product Table 89. Pfizer Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 90. Pfizer Recent Development Table 91. UCB SA Company Details Table 92. UCB SA Business Overview Table 93. UCB SA Epilepsy Product Table 94. UCB SA Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 95. UCB SA Recent Development Table 96. Medtronic PLC (Ireland) Company Details Table 97. Medtronic PLC (Ireland) Business Overview Table 98. Medtronic PLC (Ireland) Epilepsy Product Table 99. Medtronic PLC (Ireland) Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 100. Medtronic PLC (Ireland) Recent Development Table 101. NeuroPace Company Details Table 102. NeuroPace Business Overview Table 103. NeuroPace Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 104. NeuroPace Recent Development Table 105. Novartis AG Company Details Table 106. Novartis AG Business Overview Table 107. Novartis AG Epilepsy Product Table 108. Novartis AG Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 109. Novartis AG Recent Development Table 110. GW Pharmaceuticals Company Details Table 111. GW Pharmaceuticals Business Overview Table 112. GW Pharmaceuticals Epilepsy Product Table 113. GW Pharmaceuticals Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 114. GW Pharmaceuticals Recent Development Table 115. Abbott Laboratories Company Details Table 116. Abbott Laboratories Business Overview Table 117. Abbott Laboratories Epilepsy Product Table 118. Abbott Laboratories Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 119. Abbott Laboratories Recent Development Table 120. Sanofi Company Details Table 121. Sanofi Business Overview Table 122. Sanofi Epilepsy Product Table 123. Sanofi Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 124. Sanofi Recent Development Table 125. Sunovion Pharmaceuticals Company Details Table 126. Sunovion Pharmaceuticals Business Overview Table 127. Sunovion Pharmaceuticals Epilepsy Product Table 128. Sunovion Pharmaceuticals Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 129. Sunovion Pharmaceuticals Recent Development Table 130. Bausch Health Company Details Table 131. Bausch Health Business Overview Table 132. Bausch Health Epilepsy Product Table 133. Bausch Health Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 134. Bausch Health Recent Development Table 135. Takeda Company Details Table 136. Takeda Business Overview Table 137. Takeda Epilepsy Product Table 138. Takeda Revenue in Epilepsy Business (2016-2021) & (US$ Million) Table 139. Takeda Recent Development Table 140. Research Programs/Design for This Report Table 141. Key Data Information from Secondary Sources Table 142. Key Data Information from Primary Sources List of Figures Figure 1. Global Epilepsy Market Share by Type: 2020 VS 2027 Figure 2. Partial/focal Seizure Features Figure 3. Generalized Seizure Features Figure 4. Myoclonus Misses Features Figure 5. Negative Myoclonus Features Figure 6. Eyelid Myoclonus Features Figure 7. Laughter Features Figure 8. Others Features Figure 9. Global Epilepsy Market Share by Application: 2020 VS 2027 Figure 10. Hospitals Case Studies Figure 11. Neurology Centers Case Studies Figure 12. Home Care Settings Case Studies Figure 13. Ambulatory Surgical Centers Case Studies Figure 14. Others Case Studies Figure 15. Epilepsy Report Years Considered Figure 16. Global Epilepsy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Epilepsy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Epilepsy Market Share by Regions: 2020 VS 2027 Figure 19. Global Epilepsy Market Share by Regions (2022-2027) Figure 20. Global Epilepsy Market Share by Players in 2020 Figure 21. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Epilepsy Revenue in 2020 Figure 23. Global Epilepsy Revenue Market Share by Type (2016-2021) Figure 24. Global Epilepsy Revenue Market Share by Type (2022-2027) Figure 25. North America Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Epilepsy Market Share by Type (2016-2027) Figure 27. North America Epilepsy Market Share by Application (2016-2027) Figure 28. North America Epilepsy Market Share by Country (2016-2027) Figure 29. United States Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Epilepsy Market Share by Type (2016-2027) Figure 33. Europe Epilepsy Market Share by Application (2016-2027) Figure 34. Europe Epilepsy Market Share by Country (2016-2027) Figure 35. Germany Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Epilepsy Market Share by Type (2016-2027) Figure 43. Asia-Pacific Epilepsy Market Share by Application (2016-2027) Figure 44. Asia-Pacific Epilepsy Market Share by Region (2016-2027) Figure 45. China Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Epilepsy Market Share by Type (2016-2027) Figure 53. Latin America Epilepsy Market Share by Application (2016-2027) Figure 54. Latin America Epilepsy Market Share by Country (2016-2027) Figure 55. Mexico Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Epilepsy Market Share by Type (2016-2027) Figure 59. Middle East & Africa Epilepsy Market Share by Application (2016-2027) Figure 60. Middle East & Africa Epilepsy Market Share by Country (2016-2027) Figure 61. Turkey Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Epilepsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. LivaNova Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 65. Johnson & Johnson Services Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 66. Eisai Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 67. GlaxoSmithKline PLC Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 68. Pfizer Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 69. UCB SA Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 70. Medtronic PLC (Ireland) Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 71. NeuroPace Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 72. Novartis AG Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 73. GW Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 74. Abbott Laboratories Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 75. Sanofi Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 76. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 77. Bausch Health Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 78. Takeda Revenue Growth Rate in Epilepsy Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

LivaNova Johnson & Johnson Services Eisai GlaxoSmithKline PLC Pfizer UCB SA Medtronic PLC (Ireland) NeuroPace Novartis AG GW Pharmaceuticals Abbott Laboratories Sanofi Sunovion Pharmaceuticals Bausch Health Takeda